Measure to add reporting requirements for 340B-covered entities introduced
Summary
RS 32135 would require annual reporting by 340B-covered entities to several state offices; Representative Redmond said the federal 340B program involves large sums and lacks transparency; the committee introduced the request for a hearing.
Representative Jordan Redmond (District 3) introduced RS 32135, a bill that would add an annual reporting requirement for entities participating in the federal 340B drug-pricing program. Under Section 340B of the Public Health Service Act, participating manufacturers sell outpatient drugs at discounted rates to qualifying health-care organizations; RS 32135 would require covered entities to report annually to the Idaho Department of Health and Welfare, the attorney general and the state comptroller.
"A lot of the feedback I had in committee...was because there wasn't a belief that there was much transparency in this large $66,000,000,000 federal program," Redmond said, explaining the goal of increasing state-level transparency.
Representative Wheeler asked whether the fiscal note included input from the comptroller's office; Redmond said he had not spoken with the comptroller but that Health and Welfare would be able to receive the data. The committee voted to introduce RS 32135 for a hearing.
AI generated
The text on this page is AI generated. Summaries, highlights, analysis, and video transcripts are all produced from the original source material.
AI can make mistakes, so if you spot one, and we will fix it for everyone.
Note: the source content is unaltered by us. Any content source we link to, be it a video, an audio recording, or a document, is presented exactly as its publisher released it. That publisher is usually a government body, sometimes an individual official or another organisation.
